Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

MLA

Crisà, Elena, et al. “Transfusion Independence after Lenalidomide Discontinuation in Patients with Del(5q) Myelodysplastic Neoplasm: A HARMONY Alliance Study.” Leukemia, vol. 38, no. 10, Oct. 2024, pp. 2259–65. EBSCOhost, https://doi.org/10.1038/s41375-024-02360-1.

APA

Crisà, E., Mora, E., Germing, U., Bally, C., Diez Campelo, M., Myllymäki, M., Jädersten, M., Komrokji, R., Platzbecker, U., Haase, D., Hofmann, W.-K., Al Ali, N. H., Barraco, D., Bargay, J. J., Bernal, T., López Cadenas, F., Calvisi, A., Capodanno, I., Cerrano, M., … Santini, V. (2024). Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study. Leukemia, 38(10), 2259–2265. https://doi.org/10.1038/s41375-024-02360-1

Chicago

Crisà, Elena, Elvira Mora, Ulrich Germing, Cecile Bally, Maria Diez Campelo, Mikko Myllymäki, Martin Jädersten, et al. 2024. “Transfusion Independence after Lenalidomide Discontinuation in Patients with Del(5q) Myelodysplastic Neoplasm: A HARMONY Alliance Study.” Leukemia 38 (10): 2259–65. doi:10.1038/s41375-024-02360-1.